{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:24:38Z","timestamp":1747171478952,"version":"3.40.5"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.thromres.2016.11.013","type":"journal-article","created":{"date-parts":[[2016,11,14]],"date-time":"2016-11-14T08:01:28Z","timestamp":1479110488000},"page":"62-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dabigatran-related platelet thrombin response during triple anti-thrombotic therapy: A matter of time?"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6952-5038","authenticated-orcid":false,"given":"Marco","family":"Witkowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Steffens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adel","family":"Hassanein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Witkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolle","family":"Kr\u00e4nkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Doerner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Friebel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Landmesser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2016.11.013_bb0005","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/eurheartj\/ehi505","article-title":"Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation","volume":"26","author":"Nieuwlaat","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2016.11.013_bb0010","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"381","author":"Dewilde","year":"2013","journal-title":"Lancet"},{"journal-title":"Eur. J. Cardiothorac. Surg.","year":"2016","author":"Kirchhof","key":"10.1016\/j.thromres.2016.11.013_bb0015"},{"key":"10.1016\/j.thromres.2016.11.013_bb0020","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2016.11.013_bb0025","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1502000","article-title":"Idarucizumab for dabigatran reversal","volume":"373","author":"Pollack","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2016.11.013_bb0030","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.thromres.2015.06.001","article-title":"Risk of stent thrombosis and major bleeding with bivalirudin compared with active control: a systematic review and meta-analysis of randomized trials","volume":"136","author":"Kianoush","year":"2015","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2016.11.013_bb0035","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1210\/jcem.87.8.8727","article-title":"Expression of thrombin receptors in endothelial cells and neutrophils from normal and preeclamptic pregnancies","volume":"87","author":"Wang","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.thromres.2016.11.013_bb0040","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1160\/TH15-06-0467","article-title":"Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Results from a prospective, randomised, double-blind, placebo-controlled study","volume":"115","author":"Franchi","year":"2016","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2016.11.013_bb0045","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1160\/TH03-04-0245","article-title":"Regulation of protease-activated receptor 1 (PAR1) on platelets and responsiveness to thrombin receptor activating peptide (TRAP) during systemic inflammation in humans","volume":"90","author":"Reiter","year":"2003","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2016.11.013_bb0050","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1097\/CCM.0000000000001423","article-title":"Acute thrombotic occlusion of the left brachial artery after intra-arterial administration of amiodarone","volume":"44","author":"Witkowski","year":"2016","journal-title":"Crit. Care Med."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384816306247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384816306247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T08:28:53Z","timestamp":1601195333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384816306247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":10,"alternative-id":["S0049384816306247"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2016.11.013","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dabigatran-related platelet thrombin response during triple anti-thrombotic therapy: A matter of time?","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2016.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}